Various substituted 2-phenyl-1H-Benzimidazole derivatives and substituted N-[(1H-benzimidazol-2-yl) methyl]-Benzenamine derivatives were synthesized and characterized by IR, H NMR, Mass spectrometry and were evaluated for their in-vitro antimicrobial activities against Staphylococcus aureus (S. aureus ATCC 25923), Escherichia coli (E. Coli ATCC No. 8739) and antifungal activities against Aspergillus niger and Candida albicans by the means of minimum inhibitory concentration 500 µg/ml to 1 µg/ml using ciprofloxacin HCl and ketocanazole as reference standard.
Loading....